In this episode of Anesthesia Economics, Jeff McLaren is joined by Daniel Prevost, Medaxion’s Senior Vice President of Strategic Development, to break down why anesthesia stipends have become such a critical issue. They focus on the revenue side of the equation, exploring how scale, regulation, arbitration, and documentation gaps have reshaped anesthesia revenue cycle management. The conversation highlights why anesthesia billing is fundamentally different from other specialties, where revenue leakage occurs, and how better data capture and systems are essential to closing financial gaps without compromising care.

Explore the full episode page: https://www.medaxion.com/daniel-prevost-a-primer-on-anesthesia-stipends

Watch on YouTube. Learn more about Medaxion's solutions.